Category: Long COVID
Long Covid May Affect Genes Involved in Pain Signaling
Pain News Network About 16 million people in the United States have Long Covid, a poorly understood disorder that causes body aches, headaches, fatigue, insomnia, brain fog and other symptoms long after an initial infection with COVID-19. For some, the symptoms are mild, but for other they are so severe they become disabling. Why do […]
May 9, 2023
Why viral reservoirs are a prime suspect for long COVID sleuths
NPR Audio Brent Palmer’s first inkling about long COVID started in the early days of the pandemic, before the term “long COVID” even existed. Some of his friends had caught the virus while on a ski trip and returned home to Colorado with the mysterious, new illness. It was a frightening time — and an […]
May 2, 2023
Patients Living With Long COVID Offer Insight to FDA
MedPageToday Patients with long COVID and their caregivers shared how the illness has impacted their lives, the treatments they’ve tried, and their hopes for clinical trials during a virtual public meetingopens in a new tab or window on Patient-Focused Drug Development for Long COVID hosted by the FDA on Tuesday. Impacts on Daily Living Jill Anderson, a […]
May 2, 2023
Neuroscientists Find Long COVID Smell Loss Linked to Changes in the Brain
Science Tech Daily People living with long COVID who suffer from loss of smell show different patterns of activity in certain regions of the brain, a new study led by University College London (UCL) researchers has found. The research used MRI scanning to compare the brain activity of people with long COVID who lost their […]
Apr 18, 2023
A Possible Explanation for Long COVID Gains Traction
NPR Link to audio at the link While the country seemingly moves on from the pandemic, an estimated 15 million U.S. adults are suffering from long COVID. Scientists are trying to understand what causes some people to develop long COVID while others do not. NPR’s Will Stone spoke with researchers and reports on a growing […]
Apr 18, 2023
Finally, a Potential Therapy to Prevent Long COVID
MedPageToday Diabetes drug found to reduce chance of long COVID in clinical trial preprint. Hi, it’s Jeremy Faust with MedPage Today. Thanks for joining me. Today, we’re going to discuss an interesting new paper called “Outpatient Treatment of COVID-19 and the Development of Long COVID Over 10 Months.” Link to related paper in The Lancet (Preprint) […]
Mar 21, 2023
Long-covid symptoms are less common now than earlier in the pandemic
Washington Post Americans infected with the coronavirus’s omicron variant are less likely to develop symptoms typical of long covid than those who had covid-19 earlier in the pandemic, according to the largest-ever study of who is most vulnerable to being sickened — or debilitated — by the virus’s lingering effects. The analysis of nearly 5 million […]
Mar 21, 2023
What Scientists Know About Long COVID, 3 Years In
C-Net A puzzling disease left millions of patients trying to piece it together. Research is ongoing, but some causes and potential treatments are taking shape. For many people, what started out as a relatively mild case of COVID-19 persisted into a lingering condition that took weeks or months before their suffering subsided — some are […]
Mar 7, 2023
Long Covid Patients More Likely to Have Gastrointestinal Problems, Study Finds
New York Times The study, which examined patients infected early in the pandemic, found they were significantly more likely than people who didn’t get Covid to experience lingering reflux, constipation and other issues. Stomach pain, constipation, diarrhea, vomiting, bloating — these are symptoms frequently reported by people with long Covid. Now, a large new study reports that […]
Mar 7, 2023
Metformin found to reduce Long Covid in clinical trial
Inside Medicine A study posted on a preprint server operated by the medical journal The Lancet reports that Long Covid diagnoses were found to be lower in patients who received metformin (an inexpensive diabetes drug) compared to those who received placebo. The study has not yet been peer reviewed. Still, the findings are promising. Around 10.6% (1 in 9) […]
Mar 7, 2023